Arix Bioscience plc 13D and 13G filings for Harpoon Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-21 4:43 pm Purchase | 2023-10-22 | 13D | Harpoon Therapeutics, Inc. HARP | Arix Bioscience plc | 323,893 1.500% | 0 (+0.00%) | Filing |
| 2023-03-29 4:27 pm Purchase | 2023-03-23 | 13D | Harpoon Therapeutics, Inc. HARP | Arix Bioscience plc | 323,893 8.400% | 104,801 (+47.83%) | Filing |
| 2021-07-15 5:41 pm Sale | 2021-07-06 | 13D | Harpoon Therapeutics, Inc. HARP | Arix Bioscience plc | 219,092 6.700% | -1,775 (-0.80%) | Filing |
| 2021-01-12 4:15 pm Purchase | 2021-01-11 | 13D | Harpoon Therapeutics, Inc. HARP | Arix Bioscience plc | 220,867 6.900% | 1,496 (+0.68%) | Filing |
| 2020-06-01 5:00 pm Sale | 2020-05-27 | 13D | Harpoon Therapeutics, Inc. HARP | Arix Bioscience plc | 219,370 8.800% | -41,521 (-15.92%) | Filing |